Unknown

Dataset Information

0

Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomers.


ABSTRACT: Kaposi's sarcoma-associated herpesvirus (KSHV) is associated with Kaposi's sarcoma and primary effusion lymphoma (PEL). The KSHV replication and transcription activator (RTA) and latency-associated nuclear antigen (LANA) play key roles in activating KSHV lytic replication and maintaining KSHV latency, respectively. Phosphorodiamidate morpholino oligomers (PMO) are similar to short single-stranded DNA oligomers, but possess a modified backbone that confers highly specific binding and resistance to nucleases. In this study, RTA and LANA mRNA in PEL cells were targeted by antisense peptide-conjugated PMO (P-PMO) in an effort to suppress KSHV replication. Highly efficient P-PMO uptake by PEL cells was observed. Treatment of PEL cells with a RTA P-PMO (RP1) reduced RTA expression in a dose-dependent and sequence-specific manner, and also caused a significant decrease in several KSHV early and late gene products, including vIL-6, vIRF-1, and ORF-K8.1A. KSHV viral DNA levels were reduced both in cells and culture supernatants of RP1 P-PMO-treated cells, indicating that KSHV lytic replication was suppressed. Treatment of BCBL-1 cells with P-PMO against LANA resulted in a reduction of LANA expression. Cell viability assays detected no cytotoxicity from P-PMO alone, within the concentration range used for the experiments in this study. These results suggest that RP1 P-PMO can specifically block KSHV replication, and further study is warranted.

SUBMITTER: Zhang YJ 

PROVIDER: S-EPMC2390898 | BioStudies | 2007-01-01

REPOSITORIES: biostudies

Similar Datasets

2004-01-01 | S-EPMC416549 | BioStudies
2014-01-01 | S-EPMC4054365 | BioStudies
1000-01-01 | S-EPMC1900272 | BioStudies
1999-01-01 | S-EPMC104468 | BioStudies
2020-01-01 | S-EPMC7551196 | BioStudies
2017-01-01 | S-EPMC5709576 | BioStudies
2006-01-01 | S-EPMC1472065 | BioStudies
1000-01-01 | S-EPMC2681977 | BioStudies
2010-01-01 | S-EPMC2841626 | BioStudies
2018-01-01 | S-EPMC6294913 | BioStudies